Camp4 Therapeutics Corp (CAMP): Total Assets
$117.81M
As of 2025-12-31
$93.43M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $117.81M | +50.4% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $78.31M | +42.5% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $54.95M | n/a | 2025-03-27, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $117.81M | +50.4% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $19.07M | -13.4% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $22.88M | -46.9% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $37.66M | -3.0% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $31.00M | +108.2% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $353.77M | -26.6% |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $59.87M | -5.3% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $296.41M | -31.9% |
Compare CAMP, MRKR, CRVO, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗